Published in Gene Therapy Weekly, July 31st, 1995
The discovery of the PTI-1 oncogene paves the way for the development of diagnostic tests that may provide earlier detection and more reliable staging of prostate cancer. Clinical trials based on PTI-1 technology could begin within one year.
Researchers from the College of Physicians & Surgeons at Columbia-Presbyterian Medical Center, New York, New York, report their findings in the July 18, 1995, issue of the Proceedings of the National Academy of Sciences.
Using a novel gene discovery technology, principal investigator Dr. Paul B. Fisher, professor of clinical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.